Welcome to Hologic Investor Relations

 Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Recent News
Jul 5, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington...

Jul 1, 2016

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2016 on Wednesday, July 27, 2016, after the market closes. In...

Jun 22, 2016

MARLBOROUGH, Mass., June 22, 2016 -- Hologic, Inc. (Nasdaq: HOLX) announced today that the Company’s Affirm™ prone biopsy system was one of more than a dozen products showcased in front of...

Jun 20, 2016

Hologic, Inc. (NASDAQ: HOLX) and Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) – market-leading partners committed to blood safety - announced today that the U.S. Food and Drug Administration...

More ›